Atlas Trials

Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients

Clinical trial NCT04263597 · COMPLETED

Trial details

NCT number
NCT04263597
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematopoietic Stem Cell Transplant
Start date
2020-08-26
Primary completion
2025-05-23
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.